Details

NameSymbolSector
FREDUN PHARMACEUTICALS LIMITEDFREDUNPharmaceuticals
Open
2364.85
High
2364.85
Low
2270
Close
2314.65
Volume
11698
Exchange
bse
Time
15-Jun-2026

Outlook

Score:  

5.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Fredun Pharmaceuticals is  
None
Estimated Stoploss of Fredun Pharmaceuticals is ₹  
2364.85
Fredun Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Fredun Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Fredun Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Fredun Pharmaceuticals is  
Upℹ
 by  

2.75

%. 
Target
Buy @ 

1453.74

Sell @ 

2729.82

Current @ 

2314.65

Volume

The trade volumes of Fredun Pharmaceuticals have been  
Underperformingℹ
Though the volume trend for Fredun Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Fredun Pharmaceuticals is  

Down

 by  

7.66

% 

Valuation

The current market price of Fredun Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 486cr and total assets worth ₹ 486cr, the balance sheet of Fredun Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Fredun Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 3cr

. It is  
Upℹ
 by  

250

%. 

(*Mar 2025)

39.44% i.e. ₹ 28cr spent in operatingℹ
7.04% i.e. ₹ 5cr spent in investingℹ
53.52% i.e. ₹ 38cr earned in financingℹ
0% in otherℹ
Fredun Pharmaceuticals has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 2cr

. It is  
Downℹ
 by  

300

%. 

(*Mar 2024)

0% in operatingℹ
58.33% i.e. ₹ 7cr spent in investingℹ
41.67% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
The income of Fredun Pharmaceuticals is  

₹ 167cr

 and  

Profit

 is :  

₹ 7cr

(*Mar 2025)

Fredun Pharmaceuticals Profit is up by:  

40

% and Income is Up by:  

63.73

% 

(*Mar 2025)

The income of Fredun Pharmaceuticals is  

₹ 102cr

 and  

Profit

 is :  

₹ 5cr

(*Dec 2024)

Fredun Pharmaceuticals Profit is up by:  

25

% and Income is Down by:  

4.67

% 

(*Dec 2024)

The income of Fredun Pharmaceuticals is  

₹ 107cr

 and  

Profit

 is :  

₹ 4cr

(*Sep 2024)

Fredun Pharmaceuticals Profit is up by:  

0

% and Income is Up by:  

37.18

% 

(*Sep 2024)

By using this site you agree to the use of cookies to deliver a better site experience.